Literature DB >> 24279893

Treatment of pediatric anxiety disorders.

Amy Rapp1, Alice Dodds, John T Walkup, Moira Rynn.   

Abstract

This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., D-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.
© 2013 New York Academy of Sciences.

Entities:  

Keywords:  anxiety; cognitive behavioral therapy; pediatric; pharmacotherapy

Mesh:

Substances:

Year:  2013        PMID: 24279893     DOI: 10.1111/nyas.12318

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex.

Authors:  Yuki Aoyama; Kazuya Toriumi; Akihiro Mouri; Tomoya Hattori; Eriko Ueda; Akane Shimato; Nami Sakakibara; Yuka Soh; Takayoshi Mamiya; Taku Nagai; Hyoung-Chun Kim; Masayuki Hiramatsu; Toshitaka Nabeshima; Kiyofumi Yamada
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

Review 2.  Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners.

Authors:  Dilip R Patel; Cynthia Feucht; Kelly Brown; Jessica Ramsay
Journal:  Transl Pediatr       Date:  2018-01

3.  Quality measures for the care of patients with insomnia.

Authors:  Jack D Edinger; Daniel J Buysse; Ludmila Deriy; Anne Germain; Daniel S Lewin; Jason C Ong; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

Review 4.  Memantine for autism spectrum disorder.

Authors:  Amanda Brignell; Catherine Marraffa; Katrina Williams; Tamara May
Journal:  Cochrane Database Syst Rev       Date:  2022-08-25

Review 5.  D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.

Authors:  Jing Xia; Yanqiu Du; Jiyang Han; Guo Liu; Xumei Wang
Journal:  Drug Des Devel Ther       Date:  2015-04-21       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.